You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
醫思醫療(02138.HK)擬增聘人手為擴充做準備 下半年續加快併購
阿思達克 11-27 12:02
醫思醫療(02138.HK)執行董事兼常務總監李嘉豪出席業績發布會時表示,疫情期間公司雖流失了醫療旅遊的客戶,但由於集團投放了資源在營銷及IT上,成功開拓本地客源,亦帶動了本地客的消費增長,所以對下半年有期望,相信醫療板塊可有強勁增長。他透露疫情下除了美容院停業期間部分員工要放無薪假外,其他情況並無受到影響,預計未來數月亦會增聘人手為擴充做準備,亦不排除公司會再有其他投資者,強調會優先選擇可為公司提供策略性幫助的投資者,而下半年亦會加快併購。

另外他指出現時流感疫苗銷售已是去年的雙倍,料新疫苗來港後可再創高峰,而其他專科醫療的預約及銷售強勁,有信心聖誕旺季有強勁表現。

他續指疫情下規模較細的同業或面對困難,所以公司亦會繼續留意併購機會,認為現時在價錢上較易洽商,而集團在收購合併時亦會為收購對象提供「甜頭」,相信可合作共贏。他指出現時在租金方面也較易談判,亦可以談較長的租約或透過以股代租方式加強公司現金流水平,故認為集團較同業有競爭力。

在內地發展方面,他期望未來三至五年會在內地開設30-50家診所,並服務大灣區7,000萬人口,加上公司與深圳港大醫生亦有合作,相信施政報告中就香港醫療機構在大灣區發展推出的優惠政策將為集團帶來幫助,未來亦打算在一線城市如上海開設旗艦店。(el/u) ~

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account